
Marker Therapeutics Investor Relations Material
Latest events

Corporate Presentation
4 Jun, 2025

Investor Presentation
20 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Marker Therapeutics Inc
Access all reports
Marker Therapeutics Inc is a U.S.-based biotechnology company focused on the development of immunotherapies for cancer. The company’s therapeutic approach involves multi-tumor antigen-specific T cell therapies that are designed to target various hematological and solid tumors. It conducts clinical trials and research collaborations to advance its cell therapy platforms. It is headquartered in Houston, Texas, and its shares are listed on the NASDAQ.
Key slides for Marker Therapeutics Inc


Corporate Presentation
Marker Therapeutics Inc


Corporate Presentation
Marker Therapeutics Inc
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
MRKR
Country
🇺🇸 United States